OIA
CLVS

Optimum Investment Advisors’s Clovis Oncology, Inc. CLVS Stock Holding History

Optimum Investment Advisors’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-300
Closed -$2K – 952
2020
Q2 		$2K Hold
300
– – ﹤0.01% 829
2020
Q1 		$2K Sell
300
-200
-40% -$1.6K ﹤0.01% 824
2019
Q4 		$5K Hold
500
– – ﹤0.01% 856
2019
Q3 		$2K Sell
500
-200
-29% -$1.62K ﹤0.01% 946
2019
Q2 		$10K Hold
700
– – ﹤0.01% 789
2019
Q1 		$17K Hold
700
– – 0.01% 722
2018
Q4 		$13K Sell
700
-100
-13% -$2.04K ﹤0.01% 721
2018
Q3 		$23K Hold
800
– – 0.01% 699
2018
Q2 		$36K Sell
800
-100
-11% -$4.86K 0.01% 600
2018
Q1 		$48K Buy
+900
New +$52.5K 0.01% 526

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Optimum Investment Advisors's CLVS Position: Q3 2020 in Review

Optimum Investment Advisors sold out of Clovis Oncology, Inc. (CLVS) in Q3 2020, closing a stake of 300 shares — an estimated $2K sold.

Optimum Investment Advisors first reported a position in CLVS in Q1 2018 and held it in 10 quarters. The position peaked at $48K in Q1 2018. 169 funds tracked by Wall St. Rank hold CLVS as of Q3 2020.

  • Optimum Investment Advisors reported no remaining Clovis Oncology, Inc. position as of Q3 2020 after selling out during the quarter.
  • Optimum Investment Advisors sold 300 Clovis Oncology, Inc. shares in Q3 2020, an estimated $2K.
  • Optimum Investment Advisors first reported a position in Clovis Oncology, Inc. in Q1 2018 and held it in 10 quarters.
  • Optimum Investment Advisors's Clovis Oncology, Inc. position peaked at $48K in Q1 2018.
  • 169 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2020.

Based on Optimum Investment Advisors's 13F filing for Q3 2020, filed 6 Oct 2020.